Format
Sort by

Send to

Choose Destination

Links from Books

Items: 16

1.

Optimization, biological evaluation and microPET imaging of copper-64-labeled bombesin agonists, [64Cu-NO2A-(X)-BBN(7-14)NH2], in a prostate tumor xenografted mouse model.

Lane SR, Nanda P, Rold TL, Sieckman GL, Figueroa SD, Hoffman TJ, Jurisson SS, Smith CJ.

Nucl Med Biol. 2010 Oct;37(7):751-61. doi: 10.1016/j.nucmedbio.2010.04.016.

PMID:
20870150
2.

In vitro and in vivo characterization of novel 18F-labeled bombesin analogues for targeting GRPR-positive tumors.

Mu L, Honer M, Becaud J, Martic M, Schubiger PA, Ametamey SM, Stellfeld T, Graham K, Borkowski S, Lehmann L, Dinkelborg L, Srinivasan A.

Bioconjug Chem. 2010 Oct 20;21(10):1864-71. doi: 10.1021/bc100222u.

PMID:
20857927
3.

Direct one-step 18F-labeling of peptides via nucleophilic aromatic substitution.

Becaud J, Mu L, Karramkam M, Schubiger PA, Ametamey SM, Graham K, Stellfeld T, Lehmann L, Borkowski S, Berndorff D, Dinkelborg L, Srinivasan A, Smits R, Koksch B.

Bioconjug Chem. 2009 Dec;20(12):2254-61. doi: 10.1021/bc900240z.

PMID:
19921791
4.

True radiotracers: Cu-64 targeting vectors based upon bombesin peptide.

Hoffman TJ, Smith CJ.

Nucl Med Biol. 2009 Aug;36(6):579-85. doi: 10.1016/j.nucmedbio.2009.03.007. No abstract available.

PMID:
19647163
5.

Peptide receptor imaging of prostate cancer with radiolabelled bombesin analogues.

Schroeder RP, van Weerden WM, Bangma C, Krenning EP, de Jong M.

Methods. 2009 Jun;48(2):200-4. doi: 10.1016/j.ymeth.2009.04.002. Epub 2009 May 3. Review.

PMID:
19398012
6.

In vitro and in vivo analysis of [(64)Cu-NO2A-8-Aoc-BBN(7-14)NH(2)]: a site-directed radiopharmaceutical for positron-emission tomography imaging of T-47D human breast cancer tumors.

Prasanphanich AF, Retzloff L, Lane SR, Nanda PK, Sieckman GL, Rold TL, Ma L, Figueroa SD, Sublett SV, Hoffman TJ, Smith CJ.

Nucl Med Biol. 2009 Feb;36(2):171-81. doi: 10.1016/j.nucmedbio.2008.11.005.

7.

Nuclear imaging of prostate cancer with gastrin-releasing-peptide-receptor targeted radiopharmaceuticals.

Ananias HJ, de Jong IJ, Dierckx RA, van de Wiele C, Helfrich W, Elsinga PH.

Curr Pharm Des. 2008;14(28):3033-47. Review.

PMID:
18991717
8.

Synthesis, 18F-labeling, and in vitro and in vivo studies of bombesin peptides modified with silicon-based building blocks.

Höhne A, Mu L, Honer M, Schubiger PA, Ametamey SM, Graham K, Stellfeld T, Borkowski S, Berndorff D, Klar U, Voigtmann U, Cyr JE, Friebe M, Dinkelborg L, Srinivasan A.

Bioconjug Chem. 2008 Sep;19(9):1871-9. doi: 10.1021/bc800157h. Epub 2008 Aug 28.

PMID:
18754574
9.

Evaluation of the pharmacokinetic effects of various linking group using the 111In-DOTA-X-BBN(7-14)NH2 structural paradigm in a prostate cancer model.

Garrison JC, Rold TL, Sieckman GL, Naz F, Sublett SV, Figueroa SD, Volkert WA, Hoffman TJ.

Bioconjug Chem. 2008 Sep;19(9):1803-12. doi: 10.1021/bc8001375. Epub 2008 Aug 20.

10.

[64Cu-NOTA-8-Aoc-BBN(7-14)NH2] targeting vector for positron-emission tomography imaging of gastrin-releasing peptide receptor-expressing tissues.

Prasanphanich AF, Nanda PK, Rold TL, Ma L, Lewis MR, Garrison JC, Hoffman TJ, Sieckman GL, Figueroa SD, Smith CJ.

Proc Natl Acad Sci U S A. 2007 Jul 24;104(30):12462-7. Epub 2007 Jul 12.

11.

Copper chelation chemistry and its role in copper radiopharmaceuticals.

Wadas TJ, Wong EH, Weisman GR, Anderson CJ.

Curr Pharm Des. 2007;13(1):3-16. Review.

PMID:
17266585
12.

18F-labeled bombesin analogs for targeting GRP receptor-expressing prostate cancer.

Zhang X, Cai W, Cao F, Schreibmann E, Wu Y, Wu JC, Xing L, Chen X.

J Nucl Med. 2006 Mar;47(3):492-501.

13.

Radiolabeled peptide conjugates for targeting of the bombesin receptor superfamily subtypes.

Smith CJ, Volkert WA, Hoffman TJ.

Nucl Med Biol. 2005 Oct;32(7):733-40. Review.

PMID:
16243649
14.

Gastrin releasing peptide (GRP) receptor targeted radiopharmaceuticals: a concise update.

Smith CJ, Volkert WA, Hoffman TJ.

Nucl Med Biol. 2003 Nov;30(8):861-8. Review.

PMID:
14698790
15.
16.

Some pharmacological actions of alytesin and bombesin.

Erspamer V, Erpamer GF, Inselvini M.

J Pharm Pharmacol. 1970 Nov;22(11):875-6. No abstract available.

PMID:
4395815
Items per page

Supplemental Content

Write to the Help Desk